News Release / Topics | Denka Company Limited

「Possibility of Chemistry.」Denka Co.,Ltd.

2017

News Releases/Topics

2017/8/25
Denka Group Receives U.S. FDA 510k Clearance for an In-vitro Diagnostic Reagent for the Measurement of Coronary Heart Disease Risk Marker sd LDL-C
2017/8/25
Denka Completes the Acquisition of Icon Genetics GmbH, a German Bio-Pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary
2017/8/ 7
FY2017 First Quarter Summary of Consolidated Financial Results
2017/8/ 7
FY2017 First Quarter Summary of Consolidated Financial Statements
2017/6/28
Report on Third-Party Verification of Denka's GHG Emissions Data
2017/5/31
The Denka Group's Materiality Issues
2017/5/30
The Denka Group Donates Ebola Virus Rapid Diagnostic Test Kits to the Democratic Republic of the Congo
2017/5/24
Disclosure on the Internet accompanying the Notice of Convocation of the 158th Ordinary General Meeting of Shareholders
2017/5/24
Notice of Convocation of the 158th Ordinary General Meeting of Shareholders
2017/5/10
FY2016 Summary of Consolidated Financial Results
2017/5/10
FY2016 Summary of Consolidated Financial Statements
2017/4/28
Progress in Obtaining U.S. FDA Approval for a Diagnostic Reagent for the Measurement of Heart Disease Risk Marker sd LDL-C
2017/3/17
Notice of establishment New Company, Denka-KEW Genomics
2017/3/14
Price revision for Denka Poval (Denka PVA)
2017/2/15
Notice regarding the Construction of a New Hydroelectric Power Plant to Be Operated by Kurobegawa Electric Power
2017/2/14
Opening Ceremony for Denka Life Innovation Research
2017/2/ 7
Notice regarding Changes in Representative Directors at Denka Seiken
2017/2/ 7
Notice regarding Changes in Representative Directors and Other Directors as well as Executive Officers
2017/2/ 7
FY2016 Third Quarter Summary of Consolidated Financial Results
2017/2/ 7
FY2016 Third Quarter Summary of Consolidated Financial Statements
2017/1/ 4
New Year's Message